Skip to main content
. 2023 Mar 27;15(3):420–429. doi: 10.4240/wjgs.v15.i3.420

Table 2.

Vital signs, clinical manifestations and biochemical data of the patients (n = 43)

Variables
Data
Vital signs
Heart rate (time/min), mean ± SD 87.2 ± 3.1
Systolic pressure (mmHg), median (Q1, Q3) 101.0 (94.5, 113.0)
Diastolic pressure (mmHg), mean ± SD 66.2 ± 1.7
Clinical manifestations
Fever (No/Yes) 26/17
Abdominal pain (No/Yes) 1/42
Diarrhea (No/Yes) 14/29
Fecal occult blood (No/Yes) 23/20
Mucus or bloody purulent stool (No/Yes) 28/15
Lose weight (≥ 5 kg) (No/Yes) 4/39
Abdominal mass (No/Yes) 29/14
Toxic megacolon (No/Yes) 41/2
Gastrointestinal hemorrhage (No/Yes) 29/14
Intestinal obstruction (No/Yes) 19/24
Intestinal perforation (No/Yes) 34/9
Perianal disease (No/Yes) 35/8
Extraintestinal manifestations (No/Yes) 27/16
Oral ulcer (Yes) 13
Pyoderma gangrenosum (Yes) 1
Peripheral spondyloarthritis (Yes) 6
Others (Yes) 2
Biochemical data
White blood cell (× 109/L), mean ± SD 6.7 ± 0.6
Neutrophil count (× 109/L), mean ± SD 4.6 ± 0.5
Hemoglobin (g/L), mean ± SD 103.6 ± 4.5
Platelets (× 109/L), mean ± SD 343.2 ± 25.7
Alanine aminotransferase (U/L), median (Q1, Q3) 11.0 (8.0, 14.0)
Aspartate aminotransferase (U/L), median (Q1, Q3) 14.0 (10.3, 18.8)
Albumin (g/L), mean ± SD 30.6 ± 1.5
Lactate dehydrogenase (U/L), median (Q1, Q3) 127.0 (102.0, 140.0)
Creatinine (μmol/L), mean ± SD 60.7 ± 3.0
Potassium (mmol/L), mean ± SD 3.8 ± 0.1
Prothrombin time (s), mean ± SD 12.2 ± 0.2
Activated partial thromboplastin time (s), median (Q1, Q3) 29.3 (26.5, 32.9)
C-reactive protein (g/L), median (Q1, Q3) 26.3 (16.3, 71.4)